Vaginal Gel May Prevent HIV
Links shared publicly online about this topic.
- 1,010total visits
Vaginal Gel May Prevent HIV
View full resource at webmd.com
Tags: HIV, AIDS, STD, Sex and Intimacy, Women's Health
Most Recently Shared on July 19, 2010 at 10:25 pm By:
webMD: Vaginal Gel May Prevent HIV http://bit.ly/9dEluO Full http://bit.ly/9KbE03
Also Shared By:
HIV trial scrapped after gel found to be ineffective - Boston.com
boston.com — “In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.” View full resource at boston.com
Most Recently Shared on November 28, 2011 at 11:21 pm By:
HIV trial scrapped after gel found to be ineffective: In a major setback for AIDS prevention research, a clinica... http://t.co/GlJFvSlK
HIV prevention trial ends in disappointment - chicagotribune.com
chicagotribune.com — “The microbicidal vaginal gel, tenofovir, does not prevent HIV infection from infected males to uninfected females, study shows.” View full resource at chicagotribune.com
Most Recently Shared on November 28, 2011 at 8:18 pm By:
HIV prevention trial ends in disappointment http://t.co/V5MHulpb
AIDSmeds - Top Stories : Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
aidsmeds.com — “HIV prevention efforts have suffered a major setback following a Microbicide Trials Network (MTN) announcement that a vaginal gel containing the antiretroviral tenofovir has been dropped from a large ongoing clinical trial because of lackluster effectiveness. The decision to discontinue the microbicide in the Vaginal and Oral Interventions to Control the Epidemic (VOICE) study was unexpected and contradicts the optimistic results of an earlier study of the same tenofovir-based gel.” View full resource at aidsmeds.com
Most Recently Shared on November 28, 2011 at 5:25 pm By:
Top Stories : Tenofovir Microbicide Gel Falters in Major #HIV Prevention Study http://t.co/jokD5p2g #CAPRISA #VOICES #AIDS
HIV Vaginal Gel Dropped From Study - Not Effective, Trial Review Found
medicalnewstoday.com — “A tenofovir-containing microbicide vaginal gel aimed at preventing sexual transmission of HIV in females has been dropped from the VOICE trial after a routine study data review concluded that it w” View full resource at medicalnewstoday.com
Most Recently Shared on November 28, 2011 at 4:05 pm By:
HIV Vaginal Gel Dropped From Study - Not Effective, Trial Review Found http://t.co/h2S4o9L7 #healthnews
AIDSmeds - Top Stories : Two-Drug Vaginal HIV Microbicide Ring Enters U.S. Safety Study
aidsmeds.com — “For the first time ever, researchers are conducting a clinical trial evaluating the safety of a vaginal ring combining two antiretroviral (ARV) medications that may prove to be more effective and easier to use than microbicide gels.” View full resource at aidsmeds.com
Most Recently Shared on November 18, 2011 at 2:40 pm By:
Top Stories : Two-Drug Vaginal #HIV Microbicide Ring Enters U.S. Safety Study http://t.co/zWHdI4Uk #AIDS
Oral tenofovir discontinued in HIV clinical trial
news-medical.net — “A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective.” View full resource at news-medical.net
Most Recently Shared on September 29, 2011 at 2:20 pm By:
HIV/AIDS News: Oral tenofovir discontinued in HIV clinical trial: A large-scale clinical trial evaluating whethe... http://t.co/uQ64lH9y
Development Of A Vaginal Gel And PrEP Lead To Calls For A Combination Of Biomedical And Non Biomedical Approaches To HIV Prevention Policy
medicalnewstoday.com — “Researchers speaking in the first plenary session of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have offered insights into current and future HIV prevention re” View full resource at medicalnewstoday.com
Most Recently Shared on July 19, 2011 at 9:05 am By:
Development Of A Vaginal Gel And PrEP Lead To Calls For A Combination Of Biomedical And Non Biomedical Approaches To H... http://mnt.to/3YmD
Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy
eurekalert.org — “Researchers speaking in the first plenary session of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention have today offered insights into current and future HIV prevention research and discussed how biomedical developments over the past two years are beginning to shape debate on the future of HIV prevention policy.” View full resource at eurekalert.org
Most Recently Shared on July 18, 2011 at 6:49 pm By:
Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combinatio... http://bit.ly/npEO8l
VOICE study will continue as it considers what action to take after results of 2 trials
eurekalert.org — “Today, researchers from two major HIV prevention trials announced favorable results of an approach called pre-exposure prophylaxis (PrEP), which involves the use of drugs commonly used for treating HIV. One of these, the Partners PrEP study, provides the strongest evidence yet of PrEP's effectiveness. A full evaluation is needed to determine the best course for VOICE, an ongoing study of more than 5,000 women in sub-Saharan Africa testing both PrEP and the vaginal microbicide tenofovir gel.” View full resource at eurekalert.org
Most Recently Shared on July 14, 2011 at 12:13 am By:
VOICE study will continue as it considers what action to take after results of 2 trials: ( Microbicide Trials Ne... http://bit.ly/nYSHhE
Anti-HIV gel being evaluated in pregnant and breastfeeding women
eurekalert.org — “Determining whether a promising HIV prevention gel is safe for women to use while pregnant or breastfeeding is the aim of a new clinical trial being conducted by the Microbicide Trials Network (MTN). Researchers are hopeful that the study of the vaginal microbicide tenofovir gel--the first in breastfeeding women and only the second in pregnancy--will bring them closer to developing a safe and effective HIV prevention product women can use throughout their lives.” View full resource at eurekalert.org
Most Recently Shared on June 21, 2011 at 2:28 am By:
Anti-HIV gel being evaluated in pregnant and breastfeeding women: ( Microbicide Trials Network ) Determining whe... http://bit.ly/kekQVB
Tenofovir vaginal gel reformulated for rectal use - News - Virtual Medical Centre
virtualmedicalcentre.com — “A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum.” View full resource at virtualmedicalcentre.com
Most Recently Shared on March 15, 2011 at 1:06 pm By:
Tenofovir vaginal gel reformulated for rectal use http://dlvr.it/KKg9r #Healthnews
Tenofovir gel provides high level of protection against HIV in rectal tissue
new.eurekalert.org — “A gel developed to protect against HIV during vaginal sex produced a strong antiviral effect when used in the rectum, according to an early-phase study. The results, based on rectal tissue biopsies sampled from HIV-negative men and women who used the product daily for one week, provide the first-ever evidence that tenofovir gel could help reduce the risk of HIV from anal sex, even though the vaginal gel formulation may not be optimal for rectal use.” View full resource at new.eurekalert.org
Most Recently Shared on March 9, 2011 at 8:29 am By:
Tenofovir gel provides high level of protection against HIV in rectal tissue: ( Microbicide Trials Network ) A g... http://bit.ly/g4cHTz
VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel
medicalnewstoday.com — “In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir - two promising approaches for preventing HIV in women - researchers found that daily use of the vagina” View full resource at medicalnewstoday.com
Most Recently Shared on March 1, 2011 at 8:54 pm By:
VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel: In the first ... http://bit.ly/fsitlG
A Vaginal Anti-HIV Gel May Protect Anal Tissue Cells from Infection - TIME Healthland
healthland.time.com — “A new study presented Monday at the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston suggested the potential of an anti-HIV gel in protecting rectal tissue cells from infection with the virus that causes AIDS. The gel made by Gilead Sciences Inc.” View full resource at healthland.time.com
Most Recently Shared on March 1, 2011 at 2:57 pm By:
Interesting study on an anti-HIV gel in Time: http://ow.ly/45yFw
VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel
medicalnewstoday.com — “In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir - two promising approaches for preventing HIV in women - researchers found that daily use of the vagina” View full resource at medicalnewstoday.com
Most Recently Shared on March 1, 2011 at 1:54 pm By:
VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel: In the first ... http://bit.ly/dZ2Wri
Advertisement


WebMD_News
@WebMD_News
Vaginal Gel May Prevent HIV: After 20 years of failure, AIDS researchers have finally found a vaginal gel that hal... http://bit.ly/c2wwUh
1 year ago...